No description available.

<p>U okviru doktorske disertacije ispitan je nutritivni kvalitet mleka magarice balkanske rase tokom laktacije. Prosečna suva materija mleka magarice balkanske rase iznosi 9,26%. Sadržaj proteina tokom laktacije kreće se od 1,40% do 1,92%. Prosečan sadržaj mlečne masti je 0,61%, a sadržaj laktoze iznosi 6,50%. Sadržaj analiziranih minerala: Ca, Na, K, Mg, P i Zn se povećava tokom laktacije i maksimalna vrednost utvrđena je 170. dana. Primenom kapilarne elektroforeze definisan je profil proteina mleka magarice balkanske rase. Identifikovane su sledeće proteinske frakcije: &alpha;s1-kazein, &alpha;s2-kazein, &beta;-kazein (A, F), &alpha;-laktalbumin (A, C), &beta;-laktoglobulin, lizozim, laktoferin, serum albumin i imunoglobulin čiji sadržaj opada tokom perioda laktacije. Sadržaj &alpha;-laktalbumina se kreće od 3090 mg/l do 1990 mg/l, a lizozima varira od 1040 mg/l do 2970 mg/l. Navedene frakcije proteina su najzastupljenije u mleku magarice balkanske rase. Laktoferin i imunoglobulin su frakcije sa najmanjim udelom u mleku magarice balkanske rase. Kori&scaron;ćenjem gasne hromatografije/masene spektrometrije utvrđen je sastav masnih kiselina mleka. Udeo esencijalne linolne kiseline (C18:2 n6) kreće se u opsegu od 7,08%, do 9,69%, a udeo &alpha;-linoleinske kiseline (C18:3 n3) varira od 5,85% do 7,83%.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sastav mleka magarice balkanske rase kompariran je sa nutritivnim karakteristikama humanog mleka tokom 40. i 90. dana laktacije. Utvrđene su značajne razlike u sadržaju proteina mleka, mlečne masti i minerala. Odnos kazeina i proteina surutke kreće se od 0,68 do 0,75 u mleku magarice, dok u humanom mleku varira od 0,59 do 0,70. Udeo -linoleinske kiseline (C18:3 n3) je oko 2,5 puta veći u mleku magarice u odnosu na humano mleko.<br />Generalno se može zaključiti da mleko magarice balkanske rase ima specifične nutritivne karakteristike koje variraju u zavisnosti od sastava hrane za životinje i analiziranog perioda laktacije.</p> / <p>Nutritional quality of Balkan donkey milk during lactation was investigated within this thesis. The mean content of dry matter, fat and lactose in the Balkan donkey milk was 9.26%, 0.61% and 6.50%, respectively. Protein content during lactation period ranged from 1.40% to 1.92%. Content of the analyzed minerals: Ca, Na, K, Mg, Zn and P increased during the lactation period and reached their maximum value at 170th day. The protein profile of Balkans donkey milk was defined by application of capillary electrophoresis when the following protein fractions: &alpha;s1-kazein, &alpha;s2-kazein, &beta;-kazein (A, F), &alpha;-laktalbumin (A, C), &beta;-laktoglobulin, lysozyme, lactoferrin, serum albumins and immunoglobulins, whose content decreases during lactation period,were identified. &alpha;-lactalbumin contents ranged from 3090 mg/l to 1990 mg/ and lysozyme varies between 1040 mg/l to 2970 mg/l. These two protein fractions were the most abundant in the Balkan donkey milk, while lactoferrin and immunoglobulin were at least represented. The fatty acid composition of Balkan donkey milk was determined using gas chromatography/mass spectrometry. The share of the essential linoleic (C18: 2 n6) and &alpha;&nbsp;- linolenic (C18: 3 n3) acid rangred from 7.08 % to 9.69% and from 5.85 % to 7.83 %.</p><p>Nutritional quality of Balkan donkey milk has been compared with the nutritional quality of human milk during the 40th and 90th day of lactation. Significant differences in the protein content of milk, fat and minerals were found. The ratio of casein and whey protein ranged from 0.68 to 0.75 in the Balkan donkey milk, while in human milk this value varies from 0.59 to 0.70. The share of &alpha;-linolenic acid (C18:3 n3) is around 2.5 times higher in donkey than in human milk.<br />The main conclusion is that Balkan donkey milk has specific and unique nutritional quality which depend on the feed composition and on the analyzed period of lactation.</p>

<p>U radu je analiziran&nbsp; uticaj limunske kiseline na morfolo&scaron;ke, fiziolo&scaron;ke i&nbsp; biohemijske<br />karakteristike&nbsp; odabranih&nbsp; klonova&nbsp; vrba&nbsp; (Salix&nbsp; spp.)&nbsp; gajenih&nbsp; u&nbsp; zemlji&scaron;tu&nbsp; umereno zagađenom&nbsp; kadmijumom&nbsp; (Cd).&nbsp; Definisanjem&nbsp; parametara&nbsp; akumulacije,&nbsp; otpornosti&nbsp; i tolerantnosti različitih klonova vrba na prisustvo kadmijuma u podlozi, kao i uspe&scaron;nosti primene&nbsp; limunske&nbsp; kiseline&nbsp; kao&nbsp; helatora&nbsp; u&nbsp; procesu&nbsp; asistirane&nbsp; fitoremedijacije,&nbsp; mogao&nbsp; bi se&nbsp; identifikovati&nbsp; klon&nbsp; (ili&nbsp; klonovi)&nbsp; pogodan&nbsp; za&nbsp; dekontaminaciju&nbsp; zemlji&scaron;ta&nbsp; zagađenog kadmijumom. Da&nbsp; bi&nbsp; se&nbsp; postigao&nbsp; cilj&nbsp; istraživanja biljke su gajene u polu-kontrolisanim uslovima tokom 3 meseca. Eksperiment je podeljen u dve faze (dve godine istraživanja),zasnovane&nbsp; na&nbsp; razlikama&nbsp; u&nbsp; metodolo&scaron;kom&nbsp; pristupu.&nbsp; Tokom&nbsp; prve&nbsp; godine&nbsp; limunska kiselina je dodata jednom, dok je tokom druge druge godine aplikacija ovog helatora vr&scaron;ena&nbsp; u&nbsp; tri&nbsp; ponavljanja.&nbsp; U&nbsp; radu&nbsp; je&nbsp; analizaran&nbsp; sadržaj&nbsp; i&nbsp; distribucija&nbsp; Cd&nbsp; u&nbsp; zemlji&scaron;tu&nbsp; i<br />različitim&nbsp; biljnim&nbsp; organima&nbsp; (koren,&nbsp; izdanak,&nbsp; mladi&nbsp; i&nbsp; stari&nbsp; listovi);&nbsp; uticaj&nbsp; Cd i&nbsp; limunske kiseline na morfometrijske parametre: visina i prečnik izdanka, masa i povr&scaron;ina listova, broj&nbsp; listova,&nbsp; masa&nbsp; i&nbsp; zapremina&nbsp; korena;&nbsp; na&nbsp; fotosintetičke&nbsp; karakteristike:&nbsp; intenzitet fotosinteze,&nbsp; intenzitet&nbsp; transpiracije,&nbsp; stomatalnu&nbsp; provodljivost,&nbsp; intercelularnu koncentraciju&nbsp; CO2,&nbsp; efikasnost&nbsp; kori&scaron;ćenja&nbsp; vode,&nbsp; koncentraciju&nbsp; fotosintetičkih&nbsp; pigmenata; na mineralnu ishranu i distribuciju makronutrijenata u biljkama (sadržaj azota, fosfora i kalijuma);&nbsp; na&nbsp; sadržaj&nbsp; aminokiseline&nbsp; prolina&nbsp; i&nbsp; cisteina;&nbsp; na&nbsp; aktivnost&nbsp; antioksidativnih enzima&nbsp; (katalaza,&nbsp; askorbat-peroksidaza,&nbsp; gvajakol-peroksidaza),&nbsp; kao&nbsp; neezmiskih antioksidanata poput sadržaja redukovanog glutationa i tiola. Dobijeni&nbsp; rezultati&nbsp; su&nbsp; ukazali&nbsp; na&nbsp; genotipsku&nbsp; specifičnost&nbsp; analiziranih&nbsp; klonova&nbsp; vrba&nbsp; u procesu&nbsp; fitoremedijacije&nbsp; u&nbsp; zavisnosti&nbsp; od&nbsp; primenjenog&nbsp; tretmana,&nbsp; doze&nbsp; Cd&nbsp; i&nbsp; prisustva limunske kiseline. Toksično dejstvo nije bilo jasno uočljivo na morfolo&scaron;kom nivou, dok su&nbsp; primenjeni&nbsp; tretmani&nbsp; signifikantno&nbsp; uticali&nbsp; na&nbsp; fiziolo&scaron;ko-biohemijske&nbsp; procese&nbsp; u biljkama.&nbsp; Sa&nbsp; povećanjem&nbsp; sadržaja&nbsp; Cd&nbsp; u&nbsp; biljkama&nbsp; je&nbsp; utvrđena&nbsp; tendencija&nbsp; smanjenja intenziteta fotosinteze, transpiracije, kao i efikasnosti&nbsp; kor&scaron;ćenja vode, dok je primena limunske&nbsp; kiseline&nbsp; ublažila&nbsp; &scaron;tetan&nbsp; efekat&nbsp; ovog&nbsp; te&scaron;kog&nbsp; metala,&nbsp; &scaron;to&nbsp; je&nbsp; registrovano&nbsp; na<br />kombinovanim tretmanima.&nbsp; Kao odgovor na akumulaciju Cd u biljnom tkivu utvrđena<br />je&nbsp; promena&nbsp; aktivnosti&nbsp; antioksidativnih&nbsp; enzima,&nbsp; kao&nbsp; i&nbsp; neezimskih&nbsp; komponenti<br />odbrambenog&nbsp; sistema&nbsp; za&scaron;tite.&nbsp; Pored&nbsp; toga,&nbsp; u&nbsp; radu&nbsp; je&nbsp; utvrđeno&nbsp; da&nbsp; primena&nbsp; limunske kiseline&nbsp; utiče&nbsp; na&nbsp; usvajanje,&nbsp; akumulaciju&nbsp; i&nbsp; toleranciju vrba na prisustvo Cd,&nbsp; te&nbsp; rezultati ove&nbsp; studije&nbsp; imaju&nbsp; praktičan&nbsp; značaj&nbsp; u&nbsp; usavr&scaron;avanju&nbsp; tehnika&nbsp; fitoremedijacije&nbsp; i dekontaminacije zagađenih područja.</p> / <p>The role of citric acid on morphological, physiological and biochemical characteristics of selected willow clones (Salix spp.) grown in soil with moderately polluted cadmium (Cd)&nbsp; was&nbsp; presented.&nbsp; The&nbsp; aim&nbsp; of&nbsp; this&nbsp; study&nbsp; was&nbsp; to&nbsp; determine&nbsp; the&nbsp; Cd&nbsp; accumulation, translocation&nbsp; and tolerance of different willow clones, as well as the influence of citric acid as a chelator in the assisted phytoremediation process.&nbsp; In order to achieve this goal, plants&nbsp; were&nbsp; grown&nbsp; in&nbsp; semi-controlled&nbsp; conditions&nbsp; for&nbsp; 3&nbsp; months.&nbsp; The&nbsp; experiment&nbsp; was divided&nbsp; into&nbsp; two&nbsp; phases&nbsp; (two&nbsp; years&nbsp; of&nbsp; research),&nbsp; based&nbsp; on&nbsp; differences&nbsp; in&nbsp; the methodological approach, regarding the application of citric acid. During the first-year experiment, citric acid was added once, while in the second year the application of this chelator was performed in three repetitions.&nbsp; The analyses included:&nbsp; the accumulation and distribution of Cd in soil and various plant organs (root, stem, young and old leaves); influence of Cd and citric&nbsp; acid on morphometric parameters: stem hight and diameter, number&nbsp; of&nbsp; leaves,&nbsp; biomass&nbsp; and&nbsp; area&nbsp; of&nbsp; leaves,&nbsp; biomass&nbsp; and&nbsp; volume&nbsp; of&nbsp; the&nbsp; root;&nbsp; on&nbsp; photosynthetic&nbsp; characteristics:&nbsp; net&nbsp; photosynthetic&nbsp; and&nbsp; transpiration&nbsp; rate,&nbsp; water&nbsp; use efficiency, stomatal conductance, intercellular concentration of CO2, concentration of photosynthetic&nbsp; pigments;&nbsp; on&nbsp; mineral&nbsp; nutrition&nbsp; and&nbsp; distribution&nbsp; of&nbsp; macronutrients&nbsp; in plants (nitrogen, phosphorus and potassium content); on the content of the amino acid proline&nbsp; and&nbsp; cysteine;&nbsp; on&nbsp; the&nbsp; activity&nbsp; of&nbsp; antioxidant&nbsp; enzymes&nbsp; (catalase,&nbsp; ascorbate peroxidase,&nbsp; guaiacol&nbsp; peroxidase),&nbsp; as&nbsp; non- enzymatic&nbsp; components&nbsp; such&nbsp; as&nbsp; reduced glutathione and thiol content.<br />The obtained results indicated the genotypic specificity of the analyzed willow clones in the phytoremediation process, depending on the treatment applied, the Cd dose, and the presence of&nbsp; citric acid.&nbsp; The toxic effect was not evident on the morphological&nbsp; level, while&nbsp; the&nbsp; applied&nbsp; treatments&nbsp; showed&nbsp; a&nbsp; significant&nbsp; influence&nbsp; on&nbsp; the&nbsp; physiologicalbiochemical processes in the willows. The net photosynthetic rate, transpiration rate, as well as,&nbsp; water use eficiency&nbsp; showed decreasing with increasing Cd concentration in plant tissue,&nbsp; while&nbsp; the&nbsp; application&nbsp; of&nbsp; citric&nbsp; acid&nbsp; mitigated&nbsp; the&nbsp; harmful&nbsp; effect&nbsp; of&nbsp; this&nbsp; heavy metal, which was registered on combined treatments. In response to the accumulation of Cd in plant tissue, a&nbsp; change in the&nbsp; activity&nbsp; of&nbsp; anti-oxidant enzymes,&nbsp; as&nbsp; well as nonenzymatic&nbsp; components&nbsp; of&nbsp; the&nbsp; defense&nbsp; system&nbsp; has&nbsp; been&nbsp; established.&nbsp; In&nbsp; addition,&nbsp; the<br />application of citric acid showed the promotion role on the&nbsp; absorption, accumulation and tolerance of willows grown in moderately polluted soil cadmium, which has a practical significance in the improvement of phytoremediation techniques and decontamination of polluted soil.</p>

<p>Cilj ove doktorske disertacije je postavljanje<br />matematičkog modela složenog trofaznog reakcionog<br />sistem za epoksidovanje sojinog ulja in situ formiranom<br />persirćetnom kiselinom iz sirćetne kiseline i vodonik<br />peroksida u prisustvu jonoizmenjivačke smole kao<br />katalizatora. Model uzima u obzir koncentracije<br />reaktanata i produkata u vodenoj i uljnoj fazi. Pored<br />osnovnih reakcija stvaranja persirćetne kiseline i<br />epoksida, model obuhvata i sporednu reakciju otvaranja<br />epoksi prstena sa sirćetnom kiselinom. Za modelovanje<br />reakcije formiranja persirćetne kiseline na povr&scaron;ini<br />katalizatora primenjeni su Langmuir-Hinshelwood-<br />Hougen-Watson i Rideal-Eley postulati. Postavljeni<br />trofazni model predstavlja sistem običnih diferencijalnih<br />jednačina prvog reda koji opisuje promenu broja molova<br />komponenata i funkcionalnih grupa sa vremenom<br />izvođenja procesa epoksidovanja, i sadrži vi&scaron;e parametara<br />razvrstanih na kinetičke, termodinamičke i parametre koji<br />se odnose na prenos mase. Parametri modela zavise od<br />uslova izvođenja epoksidovanja i to svi od temperature, a<br />neki i od sastava i inteziteta me&scaron;anja.<br />Za konstantu hemijske ravnoteže reakcije nastajanja<br />persirćetne kiseline je izvedena semiteorijska zavisnost<br />od temperature koja daje vrednosti istog reda veličine i<br />istog smera promene sa temperaturom kao i većina<br />podataka objavljenih u literaturi.<br />Za izračunavanje koeficijenta raspodele sirćetne kiseline<br />između uljne i vodene faze potrebno je odrediti zavisnost<br />konstante fazne ravnoteže tečno-tečno sirćetne kiseline od<br />sastava i temperature. Utvrđeno je da je UNIFAC model<br />grupnih doprinosa za koeficijente aktivnosti nepogodan<br />za predskazivanje ravnoteže tečno-tečno. Eksperimentalni<br />podaci za ovu konstantu ravnoteže su uspe&scaron;no korelisani<br />UNIQUAC modelom za koeficijente aktivnosti.<br />Parametri reparametrizovane Arrheniusove zavisnosti<br />konstanti brzina reakcija i konstanti sorpcije učesnika<br />reakcije stvaranja persirćetne kiseline od temperature<br />određeni su simultano sa parametrima koji se odnose na<br />prenos mase i sa odnosom koeficijenata raspodele<br />persirćetne i sirćetne kiseline između uljne i vodene faze,<br />fitovanjem eksperimentalnih podataka epoksidovanja<br />sojinog ulja, tj. minimizacijom sume kvadrata odstupanja<br />računskih od eksperimentalno određenih vrednosti jodnog<br />broja i sadržaja epoksi kiseonika tokom epoksidovanja.<br />Fitovanje je uspe&scaron;no izvedeno primenom metode<br />Marquardta, dok su pomenute računske vrednosti<br />dobijene numeričkom integracijom sistema<br />diferencijalnih jednačina modela primenom Runge-Kutta<br />metode IV reda.</p> / <p>The objective of this doctoral thesis was development of<br />mathematical model for complex three-phase reaction<br />system for soybean oil epoxidation with peracetic acid<br />formed in situ from acetic acid and hydrogen peroxide in a<br />presence of an ion exchange resin as catalyst. The local<br />concentrations of components in water and oil phases were<br />introduced into the model. In addition to reactions of the<br />peracetic acid and epoxy compound formation, model<br />considers the side reaction of epoxy ring cleavage with<br />acetic acid. Approximate modeling of peracetic acid<br />formation was based on Langmuir-Hinshelwood-Hougen-<br />Watson and Rideal-Eley postulates. Established threephase<br />model is a system of ordinary first order differential<br />equations which describes change of components and<br />functional groups amounts with reaction time. Besides<br />kinetic parameters, model comprises the thermodynamic<br />ones as well as parameters of mass transfer between the oil<br />and water phase. All model parameters are dependent on<br />temperature and some additionally on composition and<br />intensity of stirring.<br />A semitheoretical temperature dependency of chemical<br />equilibrium constant for peracetic acid formation was<br />established. The order of magnitude and temperature trend<br />of the calculated chemical equilibrium constant are in<br />agreement with the most data given in a literature.<br />For calculation of partition coefficient for acetic acid<br />between oil and water phase, temperature and composition<br />dependency of liquid-liquid equilibrium constant for acetic<br />acid is necessary. It was found that UNIFAC model of<br />group contribution was non-applicable for the prediction<br />of the equilibrium constant. The experimental data for the<br />equilibrium constant were, however, successfully fitted by<br />UNIQUAC model.<br />Temperature dependencies of the reaction rate constants<br />and sorption constants of reactants and products in<br />peracetic acid formation reaction are expressed by<br />reparameterized Arrhenius equation. The parameters of<br />such equation were determined simultaneously with mass<br />transfer parameters and ratio of peracetic acid and acetic<br />acid partition coefficients between oil and water phase by<br />fitting the experimental data i.e. by minimization of least<br />sum of squares of deviation between the calculated and<br />experimentally determined iodine value and epoxy oxygen<br />content . Marquardt method was successfully used to fit<br />the experimental data. A fourth-ordered Runge-Kutta<br />method was applied for integrating the system of<br />differential equations of the model.</p>

<p>Doktorska disertacija razmatra solubilizaciju holesterola pomoću okso derivata žučnih kiselina, upoređuje okso derivate žučnih&nbsp; kiselina&nbsp; sa hidroksi-derivatima istih u solubilizaciji holesterola i ispituje uticaj okso derivata na vijabilnost ćelijske membrane.&nbsp; Takođe, ispituje pKa vrednost različitih okso-derivata žučnih kiselina sa ciljem da se odredi kiselinska konstanta ovih slabih organskih kiselina. Cilj određivanja pKa vrednosti jeste determinacija rastvorljivosti žučnih kiselina. Kada se primenjuju oralno u raznim farmaceutsko-tehnolo&scaron;kim formulacijama, one se primenjuju u obliku soli, koje su rastvorne u vodi. Međutim, u kiseloj sredini želuca može doći do taloženja žučne kiseline i do daljeg sprečavanja delovanja soli žučne kiseline kao solubilizatora određenih farmacutski aktivnih supstanci. Doktorska disertacija ispituje i kritičnu micelarnu koncentraciju me&scaron;ovitih micela natrijumovih soli 3 žučne kiseline (holne, deoksiholne i 7-oksodeoksiholne kiseline) i natrijum-dodecil-sulfata u različitim molskim udelima na temperaturama od 0 do 50&deg;C pomoću spektrofluorifotometra pirenskom metodom.</p> / <p>The PhD thesis discusses solubilization of cholesterol by using oxo derivatives of bile acids and compares it&nbsp; with the hydroxy-derivatives of the same in the solubilization of cholesterol, and examines the impact of the oxo derivatives to the viability of the cell membrane. Also, the pKa value of different&nbsp; tested oxo-derivatives of&nbsp; bile acids is determined. The aim of determining the pKa values is to determine the solubility of bile acids. When administered orally in various pharmaceutical-technological formulations, they are applied in the form of salts, that are soluble in water. However, the acidic medium of the stomach may cause precipitation of a bile salt and further prevent the action of bile acid salts as a solubilizers of specific pharmaceutically active substances. The PhD&nbsp;&nbsp; thesis examined the the critical micelle concentration of the mixed micelles of sodium salt of 3 bile acid (cholic, deoxycholic, and 7-oksodeoksiholne acid) and sodium dodecyl sulphate at various temperatures, the mole fractions ranging from 0 to 50 &deg;C using the method of spectrofluoriphotometry by pirene as a probe molecule.</p>

<p>Pivski trop čini približno 85% od ukupnih sporednih proizvoda proizvodnje piva, i dostupan je po veoma niskim cenama tokom čitave godine. Pivski trop ima veliku perspektivu za primenu u biotehnologiji i proizvodnji visoko vrednih proizvoda. Jedna od veoma ekolo&scaron;ki i ekonomski isplativih alternativa je upotreba pivskog tropa u proizvodnji mlečne kiseline, jer se poslednjih par decenija uočava intenzivan rast potražnje za mlečnom kiselinom. Mlečna kiselina je najvažnija hidroksikarbonska kiselina &scaron;iroko rasprostranjena u prirodi, sa velikom primenom u prehrambenoj, farmaceutskoj, tekstilnoj i hemijskoj industriji i industriji prerade kože.<br />Cilj istraživanja ove doktorske disertacije je ispitivanje primene pivskog tropa u proizvodnji mlečne kiseline. Prvo je izvr&scaron;ena optimizacija enzimske hidrolize pivskog tropa u cilju dobijanja &scaron;to je moguće veće koncentacije redukujućih &scaron;ećera neophodne za mlečno-kiselu fermentaciju. Hidrolizat pivskog tropa je dobijen enzimskom hidrolizom dodatkom komercijalnih enzima za razgradnju skroba i celuloze. Parametri čiji je uticaj na efikasnost enzimske hidrolize ispitanu su: pH vrednost, temperatura hidrolize i količina dodatih enzima. Nakon &scaron;to su određeni najbolji uslovi razgranje pivskog tropa, dobijeni postupak hidrolize je primenjen u proizvodnji hidrolizata pivskog tropa koji je kori&scaron;ćen u mlečno-kiselim fermentacijama.<br />Nakon toga je ispitana mlečno-kisela fermentacija sa dva proizvodna mikoorganizma. Kao proizvodni mikroorganizmi u mlečno-kiselim fermentacijama primenjena su dva soja bakterija mlečne kiseline: Lactobacillus fermentum PL-1 i Lactobacillus rhamnosus ATCC 7469. Ispitan je uticaj dodatka različitih koncentracija ekstrakta kvasca (0,5-5,0%) uz korekciju pH vrednosti tokom fermentacije sa dodatkom kalcijum-karbonata. U zavisnosti od udela L-(+)- i D-(-)-mlečne kiseline koje nastaju tokom fermentacije izabran je proizvodni mikroorganizam koji proizvodi vi&scaron;e L-(+)-mlečne kiseline.<br />U daljim ispitivanjima je ispitan uticaj korekcije pH pomoću natrijum-hidroksida kao i dodatak različitih koncentracija ekstrakta kvasca (0,5-5,0%) i redukujućih &scaron;ećera (2,7; 5,4 i 8,1%) u hidrolizatu pivskog tropa na mlečno-kiselu fermentaciju pomoću odabranog soja bakterija mlečne kiseline. Na osnovu dobijenih rezultata izabrana je najbolja koncentracija redukujućih &scaron;ećera i ekstrakta kvasca koji će se koristiti u daljim istraživanjima.<br />Takođe je ispitana i mogućnost zamene skupog ekstrakta kvasca i glukoze sa obnovljivim sirovinama, kao &scaron;to su pivski kvasac, džibra i bistra džibra.<br />Ispitan je uticaj dodatka različitih koncentracija pivskog kvasca (0,5-5,0%), džibre (5-20%) i bistre džibre (5-50%) pre fermentacije kao i dodatak bistre džibre u dolivnoj fermentaciji, na mlečno-kiselu fermentaciju hidrolizata pivskog tropa.<br />Ispitan je i dolivni postupak fermentacije hidrolizata pivskog tropa dodatkom glukoze, glukoze i ekstrakta kvasca i sladovine. Takođe je ispitana mogućnost izvođenja vi&scaron;e uzastopnih fermentacija sa imobilisanim ćelijama odabranog soja bakterija mlečne kiseline u kalcijum-alginatu.<br />Na osnovu eksperimentalnih rezultata zaključujeno je da je dodatak kalcijum-karbonata imao pozitivan uticaj na proizvodnju mlečne kiseline sa L. fermentum i L. rhamnosus. Sa dodatkom kalcijum-karbonata povećali su se utro&scaron;ak redukujućih &scaron;ećera, koncentracija i prinos mlečne kiseline i vijabilnost ćelija L. fermentum i L. rhamnosus. Ekstrakt kvasca i kalcijum-karbonat su imali značajan uticaj na proizvodnju mlečne kiseline sa L. fermentum i L. rhamnosus. U fermentacijama sa L. fermentum najveći prinos ukupne mlečne kiseline (44%) je postignut sa dodatkom 5,0% ekstrakta kvasca i 2,0% kalcijum-karbonata. U fermentacijama sa L. rhamnosus najveći prinos ukupne mlečne kiseline (98%) i L-(+)-mlečne kiseline (96%) je ostvaren u fermentaciji sa dodatkom 2,0% ekstrakta kvasca i 2,0% kalcijum-karbonata. Na osnovu rezultata odlučeno je da se u daljim ispitivanjima mlečno-kisele fermentacije hidrolizata pivskog tropa kao proizvodni mikoorganizam koristi L. rhamnosus.<br />Primenom natrijum-hidroksida za korekciju pH je skratila fermentaciju za 48 sati a ostvareno je i značajno povećanje zapreminske produktivnosti L-(+)-mlečne kiseline (za 200%, povećanje sa 0,21 na 0,63 g/l&middot;h-1). Korekcija pH u svim daljim istraživanjima je vr&scaron;ena sa dodatkom natrijum-hidroksida.<br />U mlečno-kiselim fermentacijama sa različitim početnim koncentracijama redukujućih &scaron;ećera (2,7; 5,4 i 8,1%) i sa dodatkom različitih koncentracija ekstrakta kvasca (0,5-5,0%), najveći prinos L-(+)-mlečne kiseline i zapreminska produktivnost od 91,29% i 1,69 g/l&middot;h-1, kao i vijabilnost ćelija L. rhamnosus od 9,7&middot;109 CFU/ml ostvareni su u fermentaciji sa početniom koncentracijom redukujućih &scaron;ećera od 5,4% i dodatkom 5,0% ekstrakta kvasca.<br />Na osnovu ostvarenih rezultata u istraživanjima sa dodatkom džibre i dodacima tokom fermentacije kao i u fermentacijama sa imobilisanim ćelijama je kori&scaron;ćen hidrolizat pivskog tropa sa početnom koncentracijom redukujućih &scaron;ećera od 5,4%.<br />U mlečno kiseloj fermentaciji sa dodatkom pivskog kvasca najveći prinos L-(+)-mlečne kiseline (89,01%) i zapreminska produktivnost (0,89 g/l&middot;h-1) L-(+)-mlečne kiseline su ostvareni u fermentaciji sa dodatkom 5,0% pivskog kvasca i korekcijom početne koncentracije redukujućih &scaron;ećera na 5,0%. Na osnovu rezultata utvrđeno je da se može izvr&scaron;iti delimična ili potpuna zamena ekstrakta kvasca pivskim kvascem uz značajno smanjenje cene podloge za mlečno-kiselu fermentaciju, bez značajnog smanjenja efikasnosti mlečno-kisele fermentacije.<br />U mlečno-kiseloj fermentaciji sa dodatkom džibre i bistre džibre najveć koncetracija, prinos i zapreminska produktivnost L-(+)-mlečne kiseline od 31,03 g/l, 86,15% i 0,93 g/l&middot;h-1, ostvareni su u fermentaciji sa dodatkom 50% bistre džibre. Najvi&scaron;a koncentracija, prinos i zapreminska produktivnost L-(+)-mlečne kiseline ostvareni u dolivnoj fermentaciji sa dodatkom glukoze i bistre džibre tokom mlečno-kisele fermentacije su iznosili su 48,02 g/l, 87,82% i 0,96 g/l&middot;h-1.<br />U fermentacijama sa dodatkom nutritijenata tokom mlečno-kisele fermentacije najveća vrednost koncetracije, prinosa i zapreminske produktivnosti L-(+)-mlečne kiseline od 116,08 g/l, 93,32% i 2,04 g/L&middot;h-1, su ostvarene u fermentaciji sa dodatkom glukoze i ekstrakta kvasca tokom fermentacije. Na osnovu rezultata utvrđeno je da se dolivni postupak fermentacije može koristiti u cilju povećanja efikasnosti mlečno-kisele fermentacije.<br />Izvr&scaron;ena je imobilizacija ćelija L. rhamnosus u kalcijum-alginatu uz izuzetno visoku vijabilnost (1010 CFU/ml). Imobilisane ćelije L. rhamnosus su uspe&scaron;no kori&scaron;ćene u tri mlečno-kisele fermentacije. Prinos L-(+)-mlečne kiseline i zapreminska produktivnost su u sve tri fermentacije bili izuzetno visoki, pri čemu su najveći prinos L-(+)-mlečne kiseline i zapreminska produktivnost od 95,2% i 1,76 g/l&middot;h-1, ostvareni u drugoj fermentaciji. Upotrebom imobilisanih ćelija L. rhamnosus je osim povećanja prinosa i zapreminske produktivnosti L-(+)-mlečne kiseline skraćena fermentacija za 12 sati u poređenju sa &scaron;aržnim fermentacijama.</p> / <p>Brewers spent grain represents (BSG) about 85% of the total by-products from brewing process and is available at low price during the whole year. Due to its chemical composition BSG has great potential use in biotechnology and production of high-value products. One of very eco-friendly and economical alternative uses of BSG is in production of lactic acid (LA), since in the last few decades the demand for the LA has significantly risen, mostly because of development of biodegradable lactic polymers, which are eco-friendly and nontoxic.<br />Lactic acid is the most important hydrocarboxylic acid with an asymmetrical carbon atom, widely distributed in nature, and it has shown great potential in fields of food, pharmaceutical, textile, leather and chemical industries.<br />The aim of this doctoral thesis was to investigate the application of BSG in lactic acid production. First, the optimization of enzymatic hydrolysis of BSG was conducted, with the goal to achieve high reducing sugar concentrations, as much as possible, that are necessary on LA fermentation. BSG hydrolysis was conducted by usage of commercial enzymes for degradation of starch and cellulose. Effect of pH value, temperature and enzyme dosage on BSG hydrolysis efficiency was investigated. After the best conditions for BSG hydrolysis were determined, the optimized procedure for BSG hydrolysis was used for the production of BSG hydrolysate that will be used in LA fermentations.<br />After optimization of BSG hydrolysis, LA fermentation by two LA producing microorganisms was investigated. The strains investigated were two LA bacteria strains: Lactobacillus fermentum PL-1 and Lactobacillus rhamnosus ATCC 7469. The effect of yeast extract (0.5; 1.0; 2.0; 3.0; 4.0, and 5.0%) addition in BSG hydrolysate, with the correction of pH value during LA fermentation by the addition of calcium-carbonate, on LA fermentation was investigated. Based on the results achieved for L-(+)- and D-(-)-LA ratio the LAB strains that produced more L-(+)-LA was chosen for further research.<br />In further research the effect of pH correction (with addition of NaOH), yeast extract (0.5, 1.0, 2.0, 3.0, 4.0, and 5.0%) addition and reducing sugar concentration (2.7; 5.4 and 8.1%) in BSG hydrolysate on LA fermentation was investigated. Based on the results achieved the best yeast extract and reducing sugars concentrations was determined and used in further analysis or research. Also the possible replacement of expensive yeast extract and glucose with cheap alternatives, like brewer`s spent grain and stillage was investigated. The effect of brewer`s spent grain (0.5; 1.0; 2.0; 3.0; 4.0, and 5.0%), whole stillage (5, 10, 15 i 20%) and thin stillage (5, 10, 15, 20, 30, 40, 50%) addition before fermentation as well as thin stillage addition in fed-batch fermentation in BSG hydrolysate on LA fermentation were investigated.<br />Also fed-batch fermentation procedure (addition of glucose, glucose and yeast extract and wort during fermentation) was investigated. The possible application of cells immobilized in Ca-alginate for LA fermentation of BSG hydrolysate was also investigated.<br />Based on the results it was concluded that BSG can be successfully utilized as a raw material in production of LA, after optimization of hydrolysis and addition of nitrogen source.<br />According to the results of chemical composition before and after optimized hydrolysis 78.6% of total cellulose was hydrolyzed.<br />Addition of calcium-carbonate had positive effect on LA production by L. fermentum i L. rhamnosus. With the addition of calcium-carbonate reducing sugar utilization, LA yield and concentration and cell viability (both L. fermentum i L. rhamnosus) increased. Addition of calcium-carbonate and yeast extract had a positive effect on LA fermentation by L. fermentum and L. rhamnosus. In LA fermentation by L. fermentum the highest LA yield (44%) was achieved with addition of 5.0% of yeast extract and 2.0% of calcium-carbonate. In L. rhamnosus fermentations the highest total LA yield (98%) and L-(+)-LA yield (96%) was reached when 2.0% of yeast extract and 2.0% of calcium-carbonate were added.<br />Based on the results achieved it was concluded that BSG hydrolysate, with the addition of yeast extract, is a good fermentation media for LA fermentation with L. rhamnosus, and it was decided that L. rhamnosus will be used in further research of LA fermentation on BSG hydrolysate.<br />Addition of NaOH instead of calcium-carbonate for the pH correction shortened the fermentation time by 48 h and increased the L-(+)-LA volumetric productivity (by 200%, from 0.21 to 0.63 g/L&middot;h-1). Based on this results pH correction in further experiments was done by addition of NaOH.<br />In LA fermentation with different reducing sugar (2.7, 5.4 and 8.1%) and yeast extract concentrations (0.5-5.0%), the highest L-(+)-LA yield and volumetric productivity of 91.29%, and 1.69 g/L&middot;h-1, respectively, as well as L. rhamnosus cell viability (9.67 log CFU/mL), were achieved with the reducing sugar content of 5.4% and yeast extract content of 5.0%.<br />Based on this results in further experiment with the addition of stillage, in fed-batch fermentation and fermentation with immobilized cell BSG hydrolysate with 5.4% of reducing sugars and 5.0% yeast extract was used.<br />In fermentation with the addition of brewer&rsquo;s spent yeast the highest L-(+)-LA yield (89.01%) and volumetric productivity (0.89 g/L&middot;h-1) were achieved in the fermentation of BSG hydrolysate with 5.0% of reducing sugar and 5.0% of brewer&rsquo;s yeast. Based on the results achieved it was concluded that yeast extract can be partial or complete replaced by brewer&rsquo;s spent yeast with significant decrease of media cost, without the decrease in LA fermentation efficiency.<br />In fermentation with the addition of thin stillage the highest L-(+)-LA concentration, yield, and volumetric productivity of 31.03 g/L, 86.15%, and 0.93 g/L&middot;h-1, respectively, was obtained in fermentation with the addition of 50% of thin stillage. The highest L-(+)-LA concentration, yield, and volumetric productivity achieved in fed-batch fermentation with the addition of glucose and thin stillage during fermentation, were 48,02 g/L, 87,82% i 0,96 g/L&middot;h-1.<br />In fed-batch fermentation the highest L-(+)-LA concentration, yield, and volumetric productivity of 116.08 g/L, 93.32%, and, 2.04 g/L h-1, respectively, were achieved in fermentation with glucose and yeast extract addition during fermentation. The results showerd that fed-batch fermentation could be used to increase L-(+)-LA fermentation efficiency<br />Immobilization of L. rhamnosus cells with high viability (1010 CFU/mL) in Ca-alginate was conducted. Immobilized cells we successfully utilized in three repeated batch fermentation. L-(+)-LA yield and volumetric productivity were very high in all three batch fermentation, with the highest results achieved (95.20% and 1.76 g/L&middot;h-1, respectively) in second fermentation. Application of immobilized L. rhamnosus cells increased L-(+)-LA yield and volumetric productivity and shortened the fermentation time for 12 h in comparison with batch fermentation.</p>

<p>Uvod Napredak hirur&scaron;kih i anesteziolo&scaron;kih tehnika učinio je hirur&scaron;ku intervenciju ugradnje totalne proteze kolena uspe&scaron;nom i bezbednom. Međutim, po&scaron;to spada u opsežne ortopedske intervencije, praćena je značajnim gubicima krvnog volumena, kao i značajnom potro&scaron;njom krvi i krvnih derivata. Trendovi u savremenoj medicini idu u pravcu restrikcije upotrebe krvi i krvnih derivata i čine se veliki napori u istraživanju i razvijanju metoda i tehnika koje mogu biti alternative alogenoj transfuziji krvi. Traneksamična kiselina koja ima antifibrinolitičko dejstvo, može dovesti do značajnog smanjenja perioperativnog krvarenja. Ciljevi istraživanja su bili utvrđivanje uticaja traneksamične kiseline na perioperativno krvarenje kod operacija ugradnje totalne proteze kolena, kao i utvrđivanje postojanja uticaja traneksamične kiseline na perioperativnu upotrebu alogene krvi kod operaacija ugradnje totalne proteze kolena. Matrijal i metode u studiju je bilo uključeno 96 bolesnika oba pola, starijih od 18 godina, kojima je bila ugrađivana primarna elektivna totalna proteza kolena. Oni su bili podeljeni u dve grupe, 48 u ispitivanoj grupi kod kojih je primenjivana traneksamična kiselina i 48 bolesnika koji su bili kontrolna grupa. Svi bolesnici su bili u spinalnoj anesteziji i primenjivana je pneumatska poveska na ekstremitetu koji se operisao. Ispitivana grupa je dobijala traneksamičnu kiselinu u dva navrata u dozi od 15 mg /kg i 10 mg/kg u vidu kontinuirane i.v. infuzije u trajanju od 15 minuta. Prvo davanje leka je bilo neposredno nakon uvoda u anesteziju. Drugo davanje leka je bilo 15 minuta pre otpu&scaron;tanja pneumatske poveske. Kontrolna grupa je dobijala istu količinu 0.9% fiziolo&scaron;kog rastvora koji je primenjivan na isti način. Intraoperativni gubitak krvi je beležen i meren kao gubitak u aspiratoru i gubitak na gazama. Postoperativn gubitak krvi se merio nakon 6, 12 sati i nakon 24 sata, kao gubitak na drenove Beležio se i broj primenjenih jedinica krvi i broj ukupno dobijenih mililitara krvi i ostalih krvnih produkata, kao i vreme njihove primene. Rezultati Postoji statistički značajna razlika u prosečnom intraoperativnom krvarenju između grupa (Z = -7,281; p = 000). Prosečno intraoperativno krvarenje u ispitivanoj grupi je bilo 100 &plusmn; 92,690 ml, a u kontrolnoj 447 &plusmn; 299,282 ml. U kontrolnoj grupi bolesnici imaju statistički značajno veće ukupno postoperativno krvarenje od bolesnika iz ispitivane grupe (T test, t=4,024, p&lt;0,01) ( ispitivana grupa 309,78&plusmn; 143,612 ml, kontrolna grupa 455,42 &plusmn; 201,177 ml). Razlika je bila statistički značajna nakon 6 sati (p &lt; 001) i nakon 12 sati u korist ispitivane grupe (p&lt;0,05). Postji statistički značajna razlika u ukupnom perioperativnom krvarenju među grupama i traneksamična kiselina je statistički značajno (p&lt;0,000) smanjila ukupno krvarenje од 919,36 ml (95%IP 822,083-1016,640) na 405, 32 ml (95% IP 353, 407-457, 231). Ukupno perioperativno krvarenje je u proseku iznosilo 662, 34 ml i kretalo se u intervalu od 100 do 1700 ml. U ispitivanoj grupi je samo 5 (10,4%) ispitanika primilo transfuziju, dok je u kontrolnoj grupi 39 (81,3%), &scaron;to je statistički značajna razlika (2=45,692; p=0,000). Prosečna količina date alogene krvi u ispitivanoj grupi je 33,33 &plusmn; 99,2 ml, dok je prosečna količina date alogene krvi u kontrolnoj grupi bila skoro deset puta veća i iznosila je 319,2 &plusmn; 230 ml, &scaron;to je statistički značajno veće (Z = -6,625; p = 000). Postoperativne vrednosti hemoglobina, hematokrita i trombocita bile su statistički značajno veće u isptivanoj grupi. Bolesnici iz ispitivane grupe su statistički značajno ranije postoperativno uzimali prvi obrok, sedeli i ustajali od bolesnika u kontrolnoj grupi. Zaključci Iz dobijenih rezultata o intraoperativnom, postoperativnom i ukupnom perioperativnom krvarenju može se zaključiti da je traneksamična kiselina veoma efikasan lek i da statistički značajno smanjuje krvarenje vezano za ugradnju totalne proteze kolena i da smanjuje upotrebu transfuzije alogene krvi za 66,7%. Traneksamična kiselina je uticajem na smanjenje perioperativnog krvarenja dovela do očuvanja vrednosti hemoglobina, hematokrita i trombocita. Bolesnici koji su dobijali traneksamičnu kiselinu su takođe imali brži i kvalitetniji neposredni postoperativni oporavak.</p> / <p>Uvod Napredak hirur&scaron;kih i anesteziolo&scaron;kih tehnika učinio je hirur&scaron;ku intervenciju ugradnje totalne proteze kolena uspe&scaron;nom i bezbednom. Međutim, po&scaron;to spada u opsežne ortopedske intervencije, praćena je značajnim gubicima krvnog volumena, kao i značajnom potro&scaron;njom krvi i krvnih derivata. Trendovi u savremenoj medicini idu u pravcu restrikcije upotrebe krvi i krvnih derivata i čine se veliki napori u istraživanju i razvijanju metoda i tehnika koje mogu biti alternative alogenoj transfuziji krvi. Traneksamična kiselina koja ima antifibrinolitičko dejstvo, može dovesti do značajnog smanjenja perioperativnog krvarenja. Ciljevi istraživanja su bili utvrđivanje uticaja traneksamične kiseline na perioperativno krvarenje kod operacija ugradnje totalne proteze kolena, kao i utvrđivanje postojanja uticaja traneksamične kiseline na perioperativnu upotrebu alogene krvi kod operaacija ugradnje totalne proteze kolena. Matrijal i metode u studiju je bilo uključeno 96 bolesnika oba pola, starijih od 18 godina, kojima je bila ugrađivana primarna elektivna totalna proteza kolena. Oni su bili podeljeni u dve grupe, 48 u ispitivanoj grupi kod kojih je primenjivana traneksamična kiselina i 48 bolesnika koji su bili kontrolna grupa. Svi bolesnici su bili u spinalnoj anesteziji i primenjivana je pneumatska poveska na ekstremitetu koji se operisao. Ispitivana grupa je dobijala traneksamičnu kiselinu u dva navrata u dozi od 15 mg /kg i 10 mg/kg u vidu kontinuirane i.v. infuzije u trajanju od 15 minuta. Prvo davanje leka je bilo neposredno nakon uvoda u anesteziju. Drugo davanje leka je bilo 15 minuta pre otpu&scaron;tanja pneumatske poveske. Kontrolna grupa je dobijala istu količinu 0.9% fiziolo&scaron;kog rastvora koji je primenjivan na isti način. Intraoperativni gubitak krvi je beležen i meren kao gubitak u aspiratoru i gubitak na gazama. Postoperativn gubitak krvi se merio nakon 6, 12 sati i nakon 24 sata, kao gubitak na drenove Beležio se i broj primenjenih jedinica krvi i broj ukupno dobijenih mililitara krvi i ostalih krvnih produkata, kao i vreme njihove primene. Rezultati Postoji statistički značajna razlika u prosečnom intraoperativnom krvarenju između grupa (Z = -7,281; p = 000). Prosečno intraoperativno krvarenje u ispitivanoj grupi je bilo 100 &plusmn; 92,690 ml, a u kontrolnoj 447 &plusmn; 299,282 ml. U kontrolnoj grupi bolesnici imaju statistički značajno veće ukupno postoperativno krvarenje od bolesnika iz ispitivane grupe (T test, t=4,024, p&lt;0,01) ( ispitivana grupa 309,78&plusmn; 143,612 ml, kontrolna grupa 455,42 &plusmn; 201,177 ml). Razlika je bila statistički značajna nakon 6 sati (p &lt; 001) i nakon 12 sati u korist ispitivane grupe (p&lt;0,05). Postji statistički značajna razlika u ukupnom perioperativnom krvarenju među grupama i traneksamična kiselina je statistički značajno (p&lt;0,000) smanjila ukupno krvarenje od 919,36 ml (95%IP 822,083-1016,640) na 405, 32 ml (95% IP 353, 407-457, 231). Ukupno perioperativno krvarenje je u proseku iznosilo 662, 34 ml i kretalo se u intervalu od 100 do 1700 ml. U ispitivanoj grupi je samo 5 (10,4%) ispitanika primilo transfuziju, dok je u kontrolnoj grupi 39 (81,3%), &scaron;to je statistički značajna razlika (2=45,692; p=0,000). Prosečna količina date alogene krvi u ispitivanoj grupi je 33,33 &plusmn; 99,2 ml, dok je prosečna količina date alogene krvi u kontrolnoj grupi bila skoro deset puta veća i iznosila je 319,2 &plusmn; 230 ml, &scaron;to je statistički značajno veće (Z = -6,625; p = 000). Postoperativne vrednosti hemoglobina, hematokrita i trombocita bile su statistički značajno veće u isptivanoj grupi. Bolesnici iz ispitivane grupe su statistički značajno ranije postoperativno uzimali prvi obrok, sedeli i ustajali od bolesnika u kontrolnoj grupi. Zaključci Iz dobijenih rezultata o intraoperativnom, postoperativnom i ukupnom perioperativnom krvarenju može se zaključiti da je traneksamična kiselina veoma efikasan lek i da statistički značajno smanjuje krvarenje vezano za ugradnju totalne proteze kolena i da smanjuje upotrebu transfuzije alogene krvi za 66,7%. Traneksamična kiselina je uticajem na smanjenje perioperativnog krvarenja dovela do očuvanja vrednosti hemoglobina, hematokrita i trombocita. Bolesnici koji su dobijali traneksamičnu kiselinu su takođe imali brži i kvalitetniji neposredni postoperativni oporavak.</p> / <p>Introduction: Total knee arthroplasty today is efficient and safe surgical procedure. Being extensive orthopaedic surgical procedure poses a risk from substantial perioperative bleeding and consecutive usage of blood products.&nbsp; Trends in modern medicine and surgery are in favor of restrictive usage of blood products and there are paramount efforts in researching and developing new techniques and methods of allogenic blood transfusion alternatives. Tranexamic acid as fibrinolytic agent is good example of substance that can be used to reduce preoperative bleeding in orthopaedic surgery. Aims of the study: We wanted to explore effects of tranexamic acid on perioperative bleeding reduction in total knee arthroplasty, and it&rsquo;s effect on reduction of blood product usage in this surgical population. Маterial and methods: We conducted double blind, randomized controlled trial with 96 adult patient (older than 18 years) in the study, 48 in two groups. All patients had elective, unilateral total knee arthroplasty. First group got tranexamic acid(TA), and second (control) group got normal saline. Surgery was performed in spinal anaesthesia with usage of pneumatic tourniquet in all patients. First group got tranexamic acid 15mg /kg/ bw и 10 mg/kg/bw as continuous intravenous infusion in duration of 15 min. Control group got same amount of normal saline. First dose of TA was given at the beginning of the operation and second dose 15 min before release of the tourniquet. Control group got normal saline at the same way. Intraoperative blood loss was measured as blood loss in suction bottle and blood loss on the surgical sponges. Postoperative blood loss was measured as blood loss in surgical wound drains after 6, 12, and 24 hours. Number of blood units and total amount of blood and blood products in milliliters were also recorded. Results There are statistically significant difference in average intraoperative bleeding between groups in favor tranexamic acid group (Z = -7,281; p = 000).Average intraoperative bleeding in TA group is 100 &plusmn; 92,690 mil, vs 447 &plusmn; 299,282 mil in control group. Patient in TA group has statistically significant less total postoperative bleeding (T test, t=4,024, p&lt;0,01)( TA group 309,78&plusmn; 143,612 mil vs,420 &plusmn; 201,177 mil). Blood loss was statistically significant less after 6 (p &lt; 001) and 12 hrs (p &lt;0,05). in TA group. Total perioperative bleeding was statistically significant less (p&lt; 0,000) in TA group and TA decreased total blood loss from 919,36 ml (95%IP 822,083-1016,640) to 405,32 ml (95%IP 353,407-457,231).Average total blood loss was 662,34 ml with interval from 100 to 1700 ml. In TA group only 5 (10,4%) patients received vs control group where 39 (81,3%) patients received allogenic blood transfusion and that is statistically significant (2=45,692; p=0,000).Average blood usage in TA group was 33,33 &plusmn; 99,2 ml vs 319,2 &plusmn; 230 ml in the control group (Z = -6,625; p = 000). Postoperative hemoglobin, haematocrit and platelets count values were statistically significant less in control group. Patient in TA group had earlier first postoperative meal, sitting and standing earlier than patient in the control group. Concliusions Data from this study clearly shows that intraoperative, postoperative and total perioperative blood loss in total knee arthroplasty are reduced with usage of tranexamic acid. Tranexamic acid is effective in reducing perioperative blood loss and usage of allogenic blood transfusion, which dropped for 66,7%.This reduced blood loss led to higher postoperative hemoglobin levels. Patients from TA group showed faster postoperative functional recover.</p>

<p>Cilj ovog istraživanja je bio da se utvrdi nivo folne kiseline u serumu (fiziolo&scaron;ka vrednost je od 16,31 do 34,88 nmol/l) i proceni težina kliničke slike instrumentima kliničke procene (HAMD 17 i 21, MADRS i CGI skala) u populaciji bolnički lečenih pacijenata, koji boluju od te&scaron;ke depresivne epizode, ili rekurententog depresivnog poremećaja, i njihov odgovor na inicijalnu antidepresivnu terapiju sprovođenu prema smernicama nacionalnog vodiča. Odgovor na antidepresivnu terapiju je određivan nakon četiri i osam nedelja lečenja u odnosu na nivo folne kiseline i prema nadoknadi folne kiseline u dozi od 15 mg dnevno (kod pacijenata koji nisu adekvatno odreagovali na terapiju). Smatrano je da je antidepresivni odgovor adekvatan ukoliko je utvrđena redukcija skora na HAMD (17, 21) i MADRS za 50%. Istraživanje je obuhvatilo 102 pacijenata (69 osoba ženskog pola i 33 osobe mu&scaron;kog pola) starosti između 18 i 70 godina života. Utvrđeno je da je snižen nivo folne kiseline u krvi imalo 41,2% pacijenata.<em> X</em>² testom je ustanovljeno da postoje značajne razlike nivoa folne kiseline u krvi u odnosu na pol. Snižen nivo folne kiseline je zastupljeniji kod osoba mu&scaron;kog pola. Pacijenati sa sniženim nivoom folne kiseline su imali inicijalno značajno vi&scaron;e skorove na skalama kliničke procene i izostanak adekvatnog terapijskog odgovora u četvrtoj nedelji lečenja. U osmoj nedelji lečenja se ta razlika u terapijskom odgovoru izgubila. Utvrđena je statistički značajna razlika u skorovima na HAMD (17) i MADRS u tri merenja u zavisnosti od nivoa folne kiseline i nadoknade uz upotrebu vi&scaron;esmerne me&scaron;ovite analize varijanse (ANOVA). Utvrđeno je da postoji značajan glavni efekat merenja (skorovi se značajno razlikuju od merenja do merenja), i značajan efekat interakcije merenja i nadoknade.</p> / <p>The aim of this paper is to establish the levels of folic acid in serum (physiological values is from 16.31 to 34.88 nmol/l) and the assessment of seriousness of clinical picture by clinical assessment instruments (HAMD 17 and 21, MADRS and CGI scales) in the population of hospitalized patients suffering from severe depressive episodes, or recurrent depressive disorder, and their response to the initial anti-depressant therapy administered according to national guidelines. The response to anti-depressant therapy was determined after four or eight weeks of treatment in relation to the levels of folic acid and according to recuperation of folic acid in the dose of 15 mg daily (in patients who did not react adequately to the therapy). It was believed that the anti-depressive response was satisfying in case of the established score reduction on HAMD (17, 21) and MADRS for 50%. The research encircled 102 patients (69 of whom female patients and 33 males) aged between 18 and 70. A reduced level of folic acid in blood was found in 41.2% of the patients. By<em> X</em>² test determined that there were significant differences in the levels of folic acid in relation to the patient gender. A reduced level was more found in male patients. The patients with reduced levels of folic acid had initially significantly higher scores on clinical assessment scales and the lack of an adequate therapeutic response in the fourth week of the treatment. In the eighth week of the treatment that difference vanished in therapeutic response. A statistically significant difference was determined on HAMD (17) and MADRS during three measurements depending on the levels of folic acid and its recuperation by using a multiway diverse analysis of variance (ANOVA). It was determined that there is a significant central effect of measurements (scores significantly differ from measurement to measurement), as well as an effect of interaction of measurements and the recuperation.</p>

<p>Poli(mlečna kiselina) (PLA) predstavlja jedan od najpopularnijih komercijalnih biorazgradivih polimera. Iako može da zameni neke od najče&scaron;će kori&scaron;ćenih sintetskih polimera, neka njegova svojstva (lo&scaron;a barijerna, termička i mehanička) jo&scaron; uvek predstavljaju prepreku u &scaron;iroj primeni, posebno za pakovanje hrane. Jedan od najsavremenijih načina prevazilaženja nedostataka u svojstvima biopolimera predstavljaju nanotehnologije.<br />U ovom radu ispitan je uticaj dodatka različitih koncentracija hidrofobnih nanočestica silicijum (IV) oksida (od 0.2 mas.% do 5 mas.%) pripremom uzoraka u rastvoru, i rastopu na toplotna, mehanička, i barijerna svojstva PLA. Morfolo&scaron;ke karakteristike uzoraka nanokompozita snimljene su pomoću skenirajuće elektronske mikroskopije (SEM). Ostvarena je izuzetno dobra disperzija i distribucija hidrofobnih čestica silicijum (IV) oksida koje su u malim udelima dodavane u poli(mlečnu kiselinu). Dobra disperzija i distribucija hidrofobnih čestica silicijum (IV) oksida ostvarena je kako pripremom nanokompozita metodom u rastvoru, tako i metodom u rastopu.<br />Toplotna svojstva PLA i pripremljenih nanokompozita proučavana su primenom diferencijalnog skenirajućeg kalorimetra (DSC), dok je stepen kristalnosti određen rasipanjem X zraka pod &scaron;irokim uglom(WAXD). Mehanička svojstva su ispitivana da bi se odredio uticaj dodatka nanočestica SiO2 na prekidnu čvrstoću i izduženje čistog PLA. Iako su prilikom pripreme materijala metodom u rastvoru, pobolj&scaron;anja mehaničkih i barijernih svojstava postignuta pri udelima silicijum (IV) oksida u rasponu od 0,2 do 5 mas.%, najznačajnija pobolj&scaron;anja postignuta su za najmanje udele nanočestica (0,2 mas.% i 0,5 mas.%). Pobolj&scaron;anja mehaničkih i barijernih svojstava nanokompozita, primenjenih metodom u rastopu, su registrovana i za udele silicijum (IV) oksida od 0,2 do 3 mas.%.<br />Takođe je ispitana mogućnost primene pripremljenog nanokompozita na osnovu poli(mlečne kiseline) i silicijum (IV) oksida za pakovanje prehrambenih proizvoda na primeru pakovanja svežeg svinjskog mesa (M. longissimus thoracis et lumborum). Ispitivanjem uticaja materijala za pakovanje svežeg mesa u vakuumu, na parametre tehnolo&scaron;kog (pH, boja), senzorskog, i mikrobiolo&scaron;kog kvaliteta mesa, utvrđeno je da su PLA kao i nanokompoziti na osnovu PLA sa različitim udelima silicijum (IV) oksida, pogodni za vakuum pakovanje i skladi&scaron;tenje svežeg svinjskog mesa.</p> / <p>Poly(lactic acid) presents one of the most popular bio-polymers for diverse applications. However, the use of PLA as food packaging material is limited due to poor barrier and mechanical properties. These properties could be improved by incorporation of nanoparticles into polymer matrix.<br />In this work neat PLA films and PLA films with different percentage of hydrophobic fumed silica nanoparticles (0,2 wt.% to 5 wt.%) were prepared by solution casting and melt blending methods. Several procedures were used to characterize the influence of different silica content on dispersion (SEM), crystalline behavior (WAXD), thermal stability (DSC, TGA), mechanical and barrier properties. It is shown that the applied techniques and selection of specific hydrophobic spherical nanofiller provide a good dispersion and distribution of silica nanoparticles in poly(lactic acid) for both film preparation methods.<br />Characteristics of films prepared by solution casting method showed improvements in mechanical and barrier properties for all loadings of nanofiller but the most significant improvements were achieved for lowest silica content (0,2 wt.% and 0,5 wt.%) The improvements in material characteristics (mechanical and barrier) for melt blending method were also achieved (for concentrations from 0,2 wt.% to 3 wt.%).<br />After film preparation, selected cuts of M. longissimus thoracis et lumborum were packed in prepred films of polymer nanocomposites, and the shelf-life characterisation was conducted on technological, sensory and microbiological paramethers of quality. After shelf-life characterisation it can be concluded that polymer nanocomposites based on PLA and silica nanoparticles could be used for packaging od fresh pork meat in vacuum.</p>

<p><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves/> <w:TrackFormatting/> <w:PunctuationKerning/> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables/> <w:SnapToGridInCell/> <w:WrapTextWithPunct/> <w:UseAsianBreakRules/> <w:DontGrowAutofit/> <w:SplitPgBreakAndParaMark/> <w:DontVertAlignCellWithSp/> <w:DontBreakConstrainedForcedTables/> <w:DontVertAlignInTxbx/> <w:Word11KerningPairs/> <w:CachedColBalance/> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="&#45;-"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument></xml><![endif]--></p><p><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" Priority="39" Name="toc 1"/> <w:LsdException Locked="false" Priority="39" Name="toc 2"/> <w:LsdException Locked="false" Priority="39" Name="toc 3"/> <w:LsdException Locked="false" Priority="39" Name="toc 4"/> <w:LsdException Locked="false" Priority="39" Name="toc 5"/> <w:LsdException Locked="false" Priority="39" Name="toc 6"/> <w:LsdException Locked="false" Priority="39" Name="toc 7"/> <w:LsdException Locked="false" Priority="39" Name="toc 8"/> <w:LsdException Locked="false" Priority="39" Name="toc 9"/> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/> <w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/> <w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/> </w:LatentStyles></xml><![endif]--><!--[if gte mso 10]><style> /* Style Definitions */ table.MsoNormalTable{mso-style-name:"Table Normal";mso-tstyle-rowband-size:0;mso-tstyle-colband-size:0;mso-style-noshow:yes;mso-style-priority:99;mso-style-qformat:yes;mso-style-parent:"";mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-para-margin-top:0in;mso-para-margin-right:0in;mso-para-margin-bottom:10.0pt;mso-para-margin-left:0in;line-height:115%;mso-pagination:widow-orphan;font-size:11.0pt;font-family:"Calibri","sans-serif";mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:"Times New Roman";mso-fareast-theme-font:minor-fareast;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;}</style><![endif]--></p><p class="MsoNormal" style="text-align:justify">Uvod: Aristolohična kiselina I je nefrotoksična i kancerogena supstanca koja je odgovorna za nefropatiju koja nastaje usled kori&scaron;ćenja herbalnih preparata i čajeva za mr&scaron;avljenje. S obzirom da se ova supstanca može naći u korovskim biljkama, smatra se jednim od glavnih ekotoksikolo&scaron;kih uzroka za nastanak balkanske endemske nefropatije čiji definitivan uzrok jo&scaron; uvek nije otkriven. Toksičnost ove supstance je dokazana na brojnim animalnim modelima, međutim mehanizmi koji dovode do o&scaron;tećenja bubrežnog parenhima jo&scaron; u potpunosti nisu razja&scaron;njeni.<span style="mso-spacerun:yes">&nbsp; </span>Cilj: Doktorska disertacija je koncipirana sa ciljem da se utvrdi uticaj toksičnog jedinjenja aristolohične kiseline I na histopatolo&scaron;ke i imunohistohemijske karakteristike tubulointersticijuma i glomerula bubrega kod mi&scaron;eva, kao i na biohemijske parametre krvi i urina koji ukazuju na o&scaron;tećenje bubrega. Materijal i metode: U ekperimentu je kori&scaron;ćeno 64 mi&scaron;a soja NMRI koji su podeljeni u tri grupe: eksperimentalna grupa (n=32) koja je dobijala aristolohičnu kiselinu I rastvorenu u polietilen glikolu (2,5% PEG 400) u dozi od 10 mg/kg telesne mase, negativna kontrolna grupa koja je dobijala 2,5% PEG 400 (n=16) i kontrolna grupa koja je dobijala fiziolo&scaron;ki rastovor (n=16). Sve životinje su tretirane intraperitonealno svakodnevno tokom sedam dana. Tokom eksperimenta 8., 17., 29. i 59. dana sakupljan je dvadesetčetvoročasovni urin 8 životinja iz eksperimentalne grupe, 4 životinje iz negativne kontrolne i 4 životinje iz kontrolne grupe. Životinje su žrtvovane 9., 18., 30. i 60. dana, uzeta im je krv, dok su bubrezi posebno odvojeni radi histopatolo&scaron;ke analize. Na bubrežnom tkivu sprovedene su histohemijske, imunohistohemijske i morfometrijske analize, dok su na uzorcima seruma i urina sprovedene biohemijske analize. Dobijeni rezultati su testirani adekvatnim statističkim metodama i prikazani su tabelarno i grafički. Rezultati: Nefrotoksin aristolohična kiselina I nakon 7 dana aplikacije izaziva značajno o&scaron;tećenje bubrežnog parenhima. Pri aplikaciji 2,5% PEG 400 i fiziolo&scaron;kog rastvora ne dolazi do vidljivog o&scaron;tećenja bubrežnog parenhima. Histopatolo&scaron;ku sliku u ranoj fazi eksperimenta (9. i 18. dan) karakteri&scaron;e akutna tubulska nekroza proksimalnih tubula. U kasnijoj fazi (30. i 60. dana) uočava se histopatolo&scaron;ka slika hroničnog intersticijalnog nefritisa sa obilnim mononuklearnim ćelijskim infiltratima limfocitnog porekla kao i postojanje blage intersticijalne fibroze. Kod eksperimentalnih životinja je morfometrijskim metodama utvrđen veći stepen bubrežnog o&scaron;tećenja tubulointersticijuma i smanjen broj podocita u glomerulu u odnosu na kontrolne grupe. Biohemijske analize kod većine eksperimentalnih životinja su pokazale veće koncentracije serumske uree nego kod kontrolnih grupa. Takođe je dokazana albuminurija u kasnijoj fazi eksperimenta koja je veća kod životinja izloženih aristolohičnoj kiselini I nego kod životinja iz kontrolnih grupa. Zaključak: Kori&scaron;ćenjem morfometrijskih metoda u okviru histopatolo&scaron;kih i imunohistohemijskih ispitivanja, uz adekvatne biohemijske analize, može se zaključiti da je aristolohična kiselina I izuzetno nefrotoksično jedinjenje koje izaziva izrazite<span style="mso-spacerun:yes">&nbsp; </span>promene tubulointersticijuma i glomerula. Podaci ovog istraživanja predstavljaju polaznu osnovu za dalja istraživanja dijagnostike u ranoj fazi nefropatija izazvanih aristolohičnim kiselinama.<span style="mso-spacerun:yes">&nbsp; </span></p> / <p>Introduction: Aristolochic acid I is a nephrotoxic and carcinogenic substance responsible for nephropathy caused by the use of herbal preparations and teas for slimminng regimen. Since this substance can be found in plants, it is considered one of the major ecotoxicological causes for the emergence of balkan endemic nephropathy whose definitive cause has not yet been revealed. The toxicity of this substance has been proven on numerous animal models, but pathophysiological mechanisms of kidney injury still remain unclear. Aim: The doctoral dissertation was designed to determine the influence of aristolochic acid on the histopathological and immunohistochemical characteristics of tubulointerstitium and glomerulus in mice, as well as the biochemical parameters of blood and urine that indicate kidney injury. Material and methods: For this study, 64 mouse of NMRI strain is used. They are divided into three groups: an experimental group (n=32) that received aristolochic acid I dissolved in polyethylene glycol (2.5% PEG 400) at a dose of 10 mg/kg of body weight, a negative control group that received 2.5% PEG 400 (n=16) and a control group that received only saline (n=16). All animals were treated intraperitoneally daily for seven days. During the experiment on the 8th, 17th, 29th and 59th day, twenty-four-hour urine was collected from 8 animals from the experimental group, 4 animals from the negative control and 4 animals from the control group. Animals were sacrificed on the 9th, 18th, 30th and 60th days, their blood was taken, while the kidneys were taken for histopathological analysis. Histochemical, immunohistochemical and morphometric analyzes were performed on renal tissue, while biochemical analyzes were performed on serum and urine samples. Obtained results were tested with adequate statistical methods and presented in a tables and graphs. Results: After 7 days of application nefrotoxin aristolochic acid I causes significant kidney injury. After application of 2.5% PEG 400 and saline, there was no visible damage to kidney parenchyma. Histopathological changes at the early stage of the experiment (9th and 18th day) were characterized by acute tubular necrosis of proximal tubules. At a later stage (30th and 60th day), chronic interstitial nephritis was observed in kidneys, with abundant mononuclear cell infiltrates in interstitium and presence of mild interstitial fibrosis. In experimental animals, a higher tubulointerstitial score of kidney injury and a decrease in the number of the podocytes in glomerulus were determined by morphometric methods, compared to the control groups. Biochemical analyzes in most experimental animals showed higher blood urea nitrogen concentrations than in control groups. High concentration of albumin in urine can be found in later stages of the experiment, and those concentrations were higher in animals exposed to aristolochic acid I than in animals from control groups.&nbsp; Conclusion: Using morphometric, histopathological and immunohistochemical methods, with adequate biochemical analysis, aristolochic acid I is proven to be an extremely nephrotoxic compound that causes drastic changes in tubulointerstitium and glomeruli of kidney parenhyma. Data from this study can be used for further research into early diagnosis of aristolochic acid nephropathy.</p>